Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T15:37:12.847Z.
Calculation as of: 2026-10-06T15:37:12.847Z.
Quote observation: 2026-10-06T15:35:16.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 764f42141b21779aba3712b54ee9373bee46ed3fd4a49ef41b5b57d04fae8ed9
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Market Cap
$246.67M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$249.41M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$243.62M
Operating Cash Flow Yield
N/A
TTM Avg
1.55%
3Y Avg
1.55%
5Y Avg
2.54%
Market Cap
$252.22M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$242.35M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$240.98M
Operating Cash Flow Yield
17.24%
TTM Avg
15.21%
3Y Avg
15.21%
5Y Avg
15.21%
Market Cap
$240.97M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Invivyd, Inc. (IVVD) | $247.82M | N/A | N/A | N/A | N/A |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $246.67M | N/A | N/A | N/A | N/A |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $249.41M | N/A | N/A | N/A | N/A |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.62M | N/A | 1.55% | 1.55% | 2.54% |
| Quantum-Si incorporated (QSI)vs › | $252.22M | N/A | N/A | N/A | N/A |
| Galectin Therapeutics Inc. (GALT)vs › | $242.35M | N/A | N/A | N/A | N/A |
| InflaRx N.V. (IFRX)vs › | $241.56M | N/A | N/A | N/A | N/A |
| Akebia Therapeutics, Inc. (AKBA)vs › | $240.98M | 17.24% | 15.21% | 15.21% | 15.21% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $240.97M | N/A | N/A | N/A | N/A |
| Century Therapeutics, Inc. (IPSC)vs › | $256.22M | N/A | 3.96% | 3.96% | 3.96% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
